Indirect effects of the COVID-19 pandemic on diagnosing, monitoring, and prescribing in people with diabetes and strategies for diabetes service recovery internationally

Diabetes Res Clin Pract. 2024 Jun:212:111693. doi: 10.1016/j.diabres.2024.111693. Epub 2024 May 7.


The COVID-19 pandemic has caused major disruptions in clinical services for people with chronic long-term conditions. In this narrative review, we assess the indirect impacts of the COVID-19 pandemic on diabetes services globally and the resulting adverse effects on rates of diagnosing, monitoring, and prescribing in people with type 2 diabetes. We summarise potential practical approaches that could address these issues and improve clinical services and outcomes for people living with diabetes during the recovery phase of the pandemic.

Keywords: Covid-19; Diabetes; Diagnosis; Monitoring; Prescribing; Service recovery.

Publication types

  • Review

MeSH terms

  • COVID-19* / epidemiology
  • Diabetes Mellitus / diagnosis
  • Diabetes Mellitus / epidemiology
  • Diabetes Mellitus, Type 2* / diagnosis
  • Diabetes Mellitus, Type 2* / drug therapy
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Pandemics
  • SARS-CoV-2*


  • Hypoglycemic Agents